| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 6 647-653, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
J Lotem and L Sachs
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.
Treatment of M1 myeloid leukemic cells with interleukin 6 (IL-6) or dexamethasone (DEX), both of which induce differentiation in these cells, down-regulated expression of the apoptosis-suppressing gene bcl-2 and the apoptosis-promoting gene bax but up-regulated expression of the apoptosis-suppressing gene bcl-XL. There was a higher expression of bcl-XL in cells treated with DEX or DEX plus IL-6 compared to cells treated with IL-6 alone. The alternatively spliced bcl-X gene, bcl-Xs, which interferes with the action of bcl-2, was not expressed. Treatment with IL-6 increased the susceptibility of these cells to induction of apoptosis by Adriamycin or cycloheximide, but treatment with DEX or with IL-6 and DEX did not. Withdrawal of DEX after up-regulation of bcl-XL resulted in a decrease in bcl-XL expression and a concomitant increase in cell susceptibility to induction of apoptosis. Another myeloid leukemia that shows barely detectable expression of bcl-2 also showed up-regulated expression of bcl-XL but no change in bax after induction of differentiation with granulocyte-macrophage colony-stimulating factor, and this reduced cell susceptibility to induction of apoptosis by Adriamycin or cycloheximide. The results indicate that the related apoptosis-regulating genes bcl-2, bcl-XL, and bax are differently regulated and that up-regulation of bcl-XL expression may compensate for down-regulation of bcl-2 in the balance between genes that control apoptosis.
This article has been cited by other articles:
![]() |
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gascoyne, R. M. Kypta, and M. d. M. Vivanco Glucocorticoids Inhibit Apoptosis during Fibrosarcoma Development by Transcriptionally Activating Bcl-xL J. Biol. Chem., May 9, 2003; 278(20): 18022 - 18029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Greenstein, K. Ghias, N. L. Krett, and S. T. Rosen Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies Clin. Cancer Res., June 1, 2002; 8(6): 1681 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Alas, C. Emmanouilides, and B. Bonavida Inhibition of Interleukin 10 by Rituximab Results in Down-Regulation of Bcl-2 and Sensitization of B-cell Non-Hodgkin's Lymphoma to Apoptosis Clin. Cancer Res., March 1, 2001; 7(3): 709 - 723. [Abstract] [Full Text] |
||||
![]() |
M Iimura, T Nakamura, S Shinozaki, B Iizuka, Y Inoue, S Suzuki, and N Hayashi Bax is downregulated in inflamed colonic mucosa of ulcerative colitis Gut, August 1, 2000; 47(2): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koga, Y. Hiromatsu, A. Jimi, S. Toda, N. Koike, and K. Nonaka Immunohistochemical Analysis of Bcl-2, Bax, and Bak Expression in Thyroid Glands from Patients with Subacute Thyroiditis J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2221 - 2225. [Abstract] [Full Text] |
||||
![]() |
M. A. Fortuno, G. Zalba, S. Ravassa, E. D'Elom, F. J. Beaumont, A. Fortuno, and J. Diez p53-Mediated Upregulation of BAX Gene Transcription Is Not Involved in Bax-{alpha} Protein Overexpression in the Left Ventricle of Spontaneously Hypertensive Rats Hypertension, June 1, 1999; 33(6): 1348 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Jelachich, C. Bramlage, and H. L. Lipton Differentiation of M1 Myeloid Precursor Cells into Macrophages Results in Binding and Infection by Theiler's Murine Encephalomyelitis Virus and Apoptosis J. Virol., April 1, 1999; 73(4): 3227 - 3235. [Abstract] [Full Text] |
||||
![]() |
L. Sevilla, C. Aperlo, V. Dulic, J. C. Chambard, C. Boutonnet, O. Pasquier, P. Pognonec, and K. E. Boulukos The Ets2 Transcription Factor Inhibits Apoptosis Induced by Colony-Stimulating Factor 1 Deprivation of Macrophages through a Bcl-xL-Dependent Mechanism Mol. Cell. Biol., April 1, 1999; 19(4): 2624 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Voorzanger-Rousselot, M.-C. Favrot, and J.-Y. Blay Resistance to Cytotoxic Chemotherapy Induced by CD40 Ligand in Lymphoma Cells Blood, November 1, 1998; 92(9): 3381 - 3387. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-h. Xu, S. Sharma, A. Gardner, Y. Tu, A. Raitano, C. Sawyers, and A. Lichtenstein Interleukin-6-Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway Blood, July 1, 1998; 92(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Kirshenbaum and D. de Moissac The bcl-2 Gene Product Prevents Programmed Cell Death of Ventricular Myocytes Circulation, September 2, 1997; 96(5): 1580 - 1585. [Abstract] [Full Text] |
||||
![]() |
A. Pecci, A. Scholz, D. Pelster, and M. Beato Progestins Prevent Apoptosis in a Rat Endometrial Cell Line and Increase the Ratio of bcl-XL to bcl-XS J. Biol. Chem., May 2, 1997; 272(18): 11791 - 11798. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Findley, L. Gu, A. M. Yeager, and M. Zhou Expression and Regulation of Bcl-2, Bcl-xl, and Bax Correlate With p53 Status and Sensitivity to Apoptosis in Childhood Acute Lymphoblastic Leukemia Blood, April 15, 1997; 89(8): 2986 - 2993. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. E. Oldenburg, R. B. Evans-Storms, and J. A. Cidlowski In Vivo Resistance to Glucocorticoid-Induced Apoptosis in Rat Thymocytes with Normal Steroid Receptor Function in Vitro Endocrinology, February 1, 1997; 138(2): 810 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sevilla, A. Zaldumbide, F. Carlotti, M. A. Dayem, P. Pognonec, and K. E. Boulukos Bcl-xL Expression Correlates with Primary Macrophage Differentiation, Activation of Functional Competence, and Survival and Results from Synergistic Transcriptional Activation by Ets2 and PU.1 J. Biol. Chem., May 18, 2001; 276(21): 17800 - 17807. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |